
- Telehealth Visits
- Insurance plan information

Chloe Atreya, MD, PhD
Gastrointestinal Medical Oncology- Telehealth Visits
- Insurance plan information



Chloe Atreya, MD, PhD
Gastrointestinal Medical Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Chloe Atreya is a medical oncologist who cares for patients with gastrointestinal cancer and co-director of the UCSF Young-Onset Colorectal Cancer Program. She is dedicated to practicing personalized medicine, integrating factors such as biomarkers to tailor treatment to each individual. She is passionate about treating each patient as a whole person and working toward health equity.
In her research, Atreya focuses on how tumor biology, lifestyle factors and the gut microbiome affect outcomes for patients with colorectal cancer. Her work has received grants from the National Institutes of Health, the American Cancer Society and other foundations. She also co-directs research hubs for integrative oncology and cancer microbiome research at the UCSF Helen Diller Family Comprehensive Cancer Center.
Atreya earned her medical degree and a doctorate in pharmacology at Yale University. She completed her internship and residency in internal medicine at the University of Washington, followed by fellowships in medical oncology and integrative medicine at UCSF.
In addition to caring for patients, Atreya is an affiliated faculty member at the UCSF Osher Center for Integrative Health and an active member of the Society for Integrative Oncology and American Society of Clinical Oncology.
Education & training
Board certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
Fellowship
- Integrative Medicine, UCSF Graduate Medical Education
- Oncology, University of CA at San Francisco - Hema/Onc GME
Residency
- Internal Medicine, University of Washington School of Medicine
Internship
- Internal Medicine, University of Washington School of Medicine
Degree
- MD, Yale University School of Medicine
My expertise
Specialties
Conditions
Locations
My goals are to improve outcomes and promote quality of life by personalizing care.
My work

Targeting liver cancer with a small pump
Clinical Trials query: q=health_gateway_id_ss%3A%28%221508%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221508%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 12 reviews
- November 7, 20255 out of 5 Stars
Our experience with Dr. Atreya has been nothing but excellent.
- August 21, 20255 out of 5 Stars
I enjoy talking with all: they are always on their game!
- August 20, 20255 out of 5 Stars
Dr. Atreya is amazing -- knowledgeable, caring, and very present! I cannot thank her enough for her time, kindness, and incredible level of care.
- July 18, 20255 out of 5 Stars
Dr. Atreya is excellent! She took her time to listen and explain everything regarding my situation and ongoing treatments in a manner that was easy to understand and thorough. She made me feel comfortable. I was impressed that my visit lasted nearly an hour as I have never experienced this before. I want to mention that her after visit summary in MyChart was excellent! It was written in an easy to understand manner that I that I understood.
- May 1, 20255 out of 5 Stars
Dr. Atreya is AMAZING! Very knowledgeable, smart and compassionate! I feel extremely grateful to be her patient!
- March 5, 20255 out of 5 Stars
Dr Atreya is AMAZING! I feel so lucky and safe with my canver care in her hands; she is so thorough, thoughtful and kind! I feel very grateful to have such a wonderful oncologist and grateful for her amazing team as well!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.